Explore how T cell engagers could transform cancer and autoimmune treatments through promising trials and key collaborations.

University of Pittsburgh School of Medicine and UPMC Hillman Cancer Center scientists have discovered a novel subset of ...

Immunotherapy is the form of treatment that redirects the immune system toward a pathogen or disease. In many cases, ...

During a Case-Based Roundtable® event, Natalie Galanina, MD, discussed data from the ZUMA-7 and TRANSFORM trials in the first ...

Scientists have discovered a novel subset of cancer-fighting immune cells that reside outside of their normal neighborhood -- known as the tertiary lymphoid structure -- where they become ...

A new study has unveiled the crucial role of low-density lipoprotein receptor-related protein 1 (LRP1) in skeletal development.

The FDA has accepted an investigational new drug application for ALLO-329, an allogeneic chimeric antigen receptor T-cell ...

University of Pittsburgh School of Medicine and UPMC Hillman Cancer Center scientists have discovered a novel subset of cancer-fighting immune cells that reside outside of their normal neighborhood – ...

Scientists engineered T cells to protect instead of kill, potentially enabling targeted treatments for autoimmune disease and ...

Infection with Zika virus in pregnancy can lead to neurological disorders, fetal abnormalities and fetal death. Until now, ...

Brain Tumor Organoids Accurately Model Patient Response to CAR T Cell Therapy Dec. 9 ... sheds light on why certain oligodendrocyte progenitor cells (OPCs) in the adult brain transform into ...

Hyderabad: Aurobindo Pharma has announced that the European Commission (EC) has granted marketing authorization in the ...